Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Treace Medical Concepts, Inc. (TMCI) had Stock-Based Compensation of $22.05M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
$45.09M |
|
$-15.36M |
|
$8.95M |
|
$36.13M |
|
$60.22M |
|
$-15.13M |
|
$-0.23M |
|
$-15.36M |
|
$-15.36M |
|
$-15.36M |
|
$-15.36M |
|
$-15.36M |
|
$-15.36M |
|
$-15.13M |
|
$-13.14M |
|
62.23M |
|
62.23M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$157.60M |
|
$25.17M |
|
$55.32M |
|
$212.92M |
|
$38.26M |
|
$53.23M |
|
$69.75M |
|
$108.02M |
|
$104.91M |
|
$83.78M |
|
$104.91M |
|
62.28M |
|
| Cash Flow Statement Financials | |
$-32.96M |
|
$31.95M |
|
$0.13M |
|
$12.98M |
|
$12.11M |
|
$-0.87M |
|
|
Stock-Based Compensation |
$22.05M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.12 |
|
-- |
|
-- |
|
0.34 |
|
0.51 |
|
80.14% |
|
-33.57% |
|
-33.57% |
|
-- |
|
-34.07% |
|
-34.07% |
|
$-41.48M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.21 |
|
1.86 |
|
48.26 |
|
-14.64% |
|
-18.33% |
|
-7.21% |
|
-9.71% |
|
$1.68 |
|
$-0.67 |
|
$-0.53 |
|